SCHLAGWORTE: Life Sciences
How big pharma companies rethink – and what start-ups can learn...
The patent cliff signifies the expiry of patent protection for major drugs, causing revenue drops as generics enter the market. Pharma companies face challenges...
Legal pathways through the valley of death
A major challenge for companies in life sciences is to live through the long years of turning innovation into clinical studies and subsequently into...
Biotech boom in Switzerland
The biotech sector is powering a strong first half year for the Swiss venture capital market. With CHF 705 million in invested capital, the...
Europe invests billions – but where are the scaled start-ups?
European countries, especially Germany, invest billions annually in basic and translational research. The scientific quality is high, the researchers are world-class, and the infrastructure...
German biotechnology needs a tailwind
Biotechnology is one of the most promising key industries – with the potential to achieve medical breakthroughs, establish new production processes and shape a...
Heading for clinical breakthrough backed by a broad investor base
Tubulis wants to improve the efficacy of cancer therapies by using antibody drug conjugates (ADCs). Three pipeline products are currently in clinical development. ‘We...
Europe’s shot at radiopharmaceutical leadership
The radiopharmaceutical industry is entering a new era. Driven by clinical breakthroughs, regulatory momentum, and investor confidence, this once-niche field is now positioned to...
‘Be patient, but persistent!’
Ghazaleh Madani, CEO of the biotech start-up CanChip, which was founded in 2023, says she is on a mission to revolutionise cancer research with...
Building microbial consortia
mbiomics, based in Neuried near Munich, is pursuing an innovative ‘microbiome engineering’ approach. The company leverages state-of-the-art analytical techniques to precisely develop bacterial consortia...
The right consortium makes all the difference
Telling a catchy equity story and starting to address different investor groups at an early company development stage – how European life sciences companies...
Special issue ‚Life Sciences‘ now online!
Our first special issue 'Life Sciences' features a cover interview with Ghazaleh Madani, founder of CanChip. She was awarded the German Startup Award as...
ASTRA Therapeutics sichert sich Seed-Finanzierung
Die 2022 gegründete ASTRA Therapeutics AG hat sich erfolgreich eine Seed-Finanzierung in Höhe von 7,75 Mio. CHF gesichert! MIG Capital investiert dabei gemeinsam mit Digitalis...
„Wissenschaft und unternehmerischer Mut gehören zusammen“
Mit dem Strüngmann Award wurde Araris Biotech für seine herausragende Rolle im ADC-Bereich ausgezeichnet. Die Auszeichnung würdigt wissenschaftliche Exzellenz und strategische Weitsicht. Für das...
Strüngmann Award 2025: Araris Biotech gewinnt Prämie
Der Gewinner des Strüngmann Awards steht fest: Dr. Dragan Grabulovski, Dr. Philipp Spycher und Dr. Isabella Attinger-Toller von Araris Biotech wurde von der Jury...
EU-Strategie: 10 Mrd. EUR für Life Sciences
Mit einer ambitionierten Strategie und einem jährlichen Fördervolumen von über 10 Mrd. EUR will die Europäische Kommission Europa bis 2030 zum weltweit attraktivsten Standort...